GlycoMimetics (GLYC) Insider Trading & Ownership $0.16 -0.01 (-6.63%) Closing price 06/13/2025Extended Trading$0.16 0.00 (0.00%) As of 06/13/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GlycoMimetics (NASDAQ:GLYC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$205.61K Get GLYC Insider Trade Alerts Want to know when executives and insiders are buying or selling GlycoMimetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GLYC Insider Buying and Selling by Quarter GlycoMimetics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/7/2024Public Equities L.P. InvusMajor ShareholderSell614$18.00$11,052.00 8/5/2024Public Equities L.P. InvusMajor ShareholderSell1,645$19.00$31,255.00 8/1/2024Public Equities L.P. InvusMajor ShareholderSell635$22.00$13,970.00 7/29/2024Public Equities L.P. InvusMajor ShareholderSell3,639$24.00$87,336.00 7/26/2024Public Equities L.P. InvusMajor ShareholderSell2,583$24.00$61,992.00 (Data available from 1/1/2013 forward) GLYC Insider Trading Activity - Frequently Asked Questions Who is on GlycoMimetics' Insider Roster? The list of insiders at GlycoMimetics includes Brian M Hahn, Bruce S Johnson, Daniel M Junius, Edwin Rock, Public Equities L.P. Invus, and Scott D Sandell. Learn more on insiders at GLYC. What percentage of GlycoMimetics stock is owned by insiders? 8.70% of GlycoMimetics stock is owned by insiders. Learn more on GLYC's insider holdings. Which GlycoMimetics insiders have been buying company stock? The following insider purchased GLYC shares in the last 24 months: Edwin Rock ($95,800.00). How much insider buying is happening at GlycoMimetics? Insiders have purchased a total of 2,250 GLYC shares in the last 24 months for a total of $95,800.00 bought. Which GlycoMimetics insiders have been selling company stock? The following insider sold GLYC shares in the last 24 months: Public Equities L.P. Invus ($205,605.00). How much insider selling is happening at GlycoMimetics? Insiders have sold a total of 9,116 GlycoMimetics shares in the last 24 months for a total of $205,605.00 sold. More Insider Trading Tools from MarketBeat Related Companies Iterum Therapeutics Insider Trades Pluri Insider Trades Shattuck Labs Insider Trades Eagle Pharmaceuticals Insider Trades Akari Therapeutics Insider Trades Acrivon Therapeutics Insider Trades Karyopharm Therapeutics Insider Trades Mersana Therapeutics Insider Trades Artiva Biotherapeutics Insider Trades PepGen Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Micron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield WatchlistInsider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors? This page (NASDAQ:GLYC) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlycoMimetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlycoMimetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GLYC Stock Alerts